Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$1.02 - $10.6 $31,881 - $331,313
31,256 Added 31.86%
129,351 $135,000
Q2 2022

Aug 11, 2022

BUY
$0.97 - $1.77 $21,689 - $39,577
22,360 Added 29.52%
98,095 $101,000
Q1 2022

May 16, 2022

BUY
$1.53 - $3.25 $115,874 - $246,138
75,735 New
75,735 $134,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $299M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.